Please login to the form below

Not currently logged in
Email:
Password:

UK Market Access

This page shows the latest UK Market Access news and features for those working in and with pharma, biotech and healthcare.

England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right

England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right

It also demonstrates, however, a new determination to take early control of pricing and market entry negotiations with pharma. ... be keen to see the arrival of Roche’s rival entrectinib, to allow greater leverage in market access negotiations.

Latest news

  • NHS England wants money-back guarantee on Orkambi NHS England wants money-back guarantee on Orkambi

    It has proposed a two-year managed access arrangement for Orkambi and Symekvi. ... NHS England has pointed out that just in the last few weeks it has signed novel market access deals with Roche and Biogen, and called on Vertex to be similarly “willing

  • Still no breakthrough on Orkambi talks, MPs want answers Still no breakthrough on Orkambi talks, MPs want answers

    The deadlock over access to Orkambi has now reached its three year milestone, thanks to a clash between NICE and NHS England and Vertex over the price of the drug. ... Health select committee chair Dr Sarah Wollaston said: "The best interests of patients

  • Spinraza managed access deal in England breaks deadlock for Biogen Spinraza managed access deal in England breaks deadlock for Biogen

    The announcement is the latest sign that NHS England’s new hard bargaining but speedy approach to price talks is helping to accelerate market access in the country – even though pharma ... Muscular Dystrophy UK points out that Spinraza is only the

  • Novartis and Sanofi heads take on UK pharma leadership roles Novartis and Sanofi heads take on UK pharma leadership roles

    Hugo Fry, Sanofi’s UK managing director, has been appointed as the ABPI’s vice-president. ... These include contested new restrictions on medicines spending and market access in England, but most especially Brexit, which has thrown a cloud of

  • England opens new NHS ‘front door’ to health innovators England opens new NHS ‘front door’ to health innovators

    An upgrade to existing ACC initiative. The UK government has unveiled an upgrade to its Accelerated Access Collaborative (ACC) initiative, aimed at creating a single ‘front door’ into the NHS for ... support the NHS to more quickly adopt clinically

More from news
Approximately 41 fully matching, plus 43 partially matching documents found.

Latest Intelligence

  • The Orkambi row explained The Orkambi row explained

    Is the UK an extreme outlier in terms of market access for Orkambi? ... The long stalemate certainly puts the UK far behind many comparable countries regarding Orkambi access.

  • #OrkambiNow? #OrkambiNow?

    This would represent a transition towards an outcomes-based reimbursement system, which is certain to be central to market access for many novel drugs in the future. ... For people with CF and these rare conditions, this vision of a less adversarial and

  • The UK’s new five-year pricing agreement The UK’s new five-year pricing agreement

    Nevertheless, it provides some stability and predictability for the UK sector, where the uncertainties of Brexit continue to threaten the overall attractiveness of the UK market. ... Mike Thompson, chief executive, ABPI. Having agreed a ceiling on growth,

  • Comment: the new UK pricing deal – welcome news, but lessons to be learned Comment: the new UK pricing deal – welcome news, but lessons to be learned

    Leslie Galloway, chairman of EMIG reflects on the new UK government-pharma industry pricing agreement. ... Leslie Galloway is chairman of the Ethical Medicines Industry Group EMIG, whose 270 member companies supply 50% of branded medicines by volume in

  • Pharma: in search of the sustainable ‘win win’ with the NHS Pharma: in search of the sustainable ‘win win’ with the NHS

    Ahead of the meeting, I caught up with one of our industry speakers, Fiona Bride, head of UK market access strategy at Novartis. ... This is of particular interest because it was devised specifically for the UK market.

More from intelligence
Approximately 5 fully matching, plus 17 partially matching documents found.

Latest appointments

  • RJW & Partners appoints new director RJW & Partners appoints new director

    She joins the firm from pharma service provider ICON, where she served as principal and head of EU pricing and market access. ... Prior to that Beecher was with  Bristol-Myers Squibb, where she was UK pricing and market access manager, and before that

  • PM Society appoints new chairman PM Society appoints new chairman

    Bradley previously served as the PM Society's market access lead, and is brand manager for Shire's internal medicine business unit, making him the society's first chair from a ... He has since held a series of increasingly senior positions at Shire,

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... He also brings experience form Boehringer Ingelheim, where he

  • GalbraithWight appoints Eithne McShane and Steve Mazzarese GalbraithWight appoints Eithne McShane and Steve Mazzarese

    McShane (pictured right) brings experience to the role from Bayer, where she served as market access manager, Novartis Oncology and Therabel Europe. ... In her new role at UK-based market access consultancy she will be tasked with growing

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    Will take up commercial role at UK pharma bodyat the end of the month. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Adelphi Research UK wins Agency of the Year at BHBIA Conference

    Adelphi Research UK’s MD Rachel Medcalf also received an award for her contribution as Chair of the BHBIA Ethics and Compliance committee. ... Adelphi Research UK is based south Manchester, in Bollington, Cheshire and is part of the Adelphi Group of

  • No Voice, No Choice

    Experts in UK market research, the agency challenges their clients to think differently by pushing the boundaries to help them drive change. ... brand communications and enabling market access.

  • 6 Ways to Make MROC’s Rock

    Adelphi Research UK are experts in GDPR with a dedicated team linked closely with BHBIA who can offer more guidance on any concerns you may have with compliance.  .

  • 6 Ways to Ensure Payer Research Delivers

    Our Market Access team has reflected on our extensive experience researching a broad range of payer audiences and come up with the following ‘musts’ for ensuring payer research sings. ... Adelphi has a dedicated Market Access consultancy to help you

  • The Biosimilar Challenge

    However, the once stable market is now under attack from a number of biosimilars that pose a significant challenge and threaten the originator brands. . ... In fact, recent self-funded work, showed that 89% of UK payers now positively endorse the use of

More from PMHub
Approximately 0 fully matching, plus 22 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics